Q1 2026 May 21, 2026

RLX Technology’s shares rose modestly by 2.4% following its Q1 2026 earnings release, reflecting a generally stable market reception without a clear catalyst to push the stock higher or lower.

Key takeaways

Revenue grew sharply on a reported basis, with management highlighting international expansion and resilient performance in Mainland China.
The company underscored the strategic importance of Europe as a high-barrier market, emphasizing measured, long-term investment rather than immediate scale.
The newly operational Nexus hub consolidates R&D, manufacturing, and commercial operations, purportedly improving efficiency and proprietary technology protection.
Regulatory changes, such as the UK’s tobacco act, were positioned as structural tailwinds for harm reduction products, supporting a favorable regulatory outlook.
Management reaffirmed a focus on innovation, compliance, and sustainable, quality-led global growth but provided limited concrete financial metrics or outlook details in the transcript excerpt.

Q3 2025 Nov 15, 2025

RLX Technology delivered strong financial results in Q3 2025, with a 49% year-over-year revenue growth to RMB 1.1 billion and a notable increase in profitability, despite ongoing market challenges in Mainland China.

Key takeaways

Strong international performance, with 70–80% of revenue now derived from global markets, driven by innovative product launches and retail strategies.
Gross profit margin improved by 4 percentage points year-over-year, reflecting operational excellence and disciplined execution.
Revenue from Mainland China grew modestly to RMB 320 million, although the market remains significantly impacted by unregulated competition.
Continued strategic investments, including a significant equity stake in a leading European e-vapor company, bolster market intelligence and future growth prospects.
Proactive adaptation to regulatory changes in key markets, including the UK, successfully maintained market position amid industry contractions.

Q2 2025 Aug 22, 2025

RLX Technology delivered a robust Q2 2025 with a 40% year-over-year increase in net revenues to RMB 880 million and a non-GAAP operating profit of RMB 116 million, highlighting strong execution amid evolving market dynamics.

Key takeaways

Net revenues surged to RMB 880 million, driven by strategic international expansion and adaptability to regulatory changes.
Emphasis on a multi-category product portfolio is strengthening market leadership, with successful pilot programs for modern oral nicotine products.
The "big puff effect" has influenced product innovation, leading to the launch of high-capacity e-vapor devices tailored to consumer preferences.
Commitment to sustainable solutions is evident in the shift from disposables to cartridge-based technologies, positioning RLX competitively in an evolving market landscape.

RLX Technology Inc. Earnings Recaps